Compounds > 2,3,4,6-tetrachlorophenol
Page last updated: 2024-08-17

2,3,4,6-tetrachlorophenol and Central Nervous System Disease

2,3,4,6-tetrachlorophenol has been researched along with Central Nervous System Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Malinowski, B; Puk, O; Wiciński, M1

Reviews

1 review(s) available for 2,3,4,6-tetrachlorophenol and Central Nervous System Disease

ArticleYear
Cenobamate: Neuroprotective Potential of a New Antiepileptic Drug.
    Neurochemical research, 2021, Volume: 46, Issue:3

    Topics: Animals; Carbamates; Central Nervous System Diseases; Chlorophenols; Drug Repositioning; GABA-A Receptor Agonists; Glutamic Acid; Humans; Neuroprotective Agents; Signal Transduction; Tetrazoles; Voltage-Gated Sodium Channel Blockers

2021